Abstract
Many natural products, which derived from plants, animals, and microorganisms, have been isolated as bioactive compounds with great therapeutic potential for cancer, but as a fungus, lichen has long been neglected in this area. The special symbiotic form of fungi and algae and worldwide distribution even extreme habitat of lichen contribute to its biological and chemical diversity, so, lichen becomes an amazing resource for the discovery of new anticancer drugs. The aim of this review is to show the value of lichen as a potential resource of anticancer drugs, especially highlight several lichen metabolisms and their derivatives, which can show the potentials to inhibit cellular proliferation or cytotoxicity and trigger apoptosis of cancer cells. To identify the new lead-compounds from lichen and elucidate the active principles with therapeutic potential for cancer, it is essential to establish a high-throughput screening program and dedicated collaboration among lichenologists, chemists, pharmacologists, and biologists.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Micheli A, Mugnol E, Krogh V et al, the Europreval Working Group (2002) Cancer prevalence in European reistry areas. Ann Oncol 13:840−865
Da Rocha AB, Lopes RM, Schwartsmann G (2001) Natural products in anticancer therapy. Curr Opin Pharmacol 1:364–369
Sun YY, Xun KL, Wang YT et al (2009) A systematic review of the anticancer properties of berberine a natural product from Chinese herbs. Anti-Canc D 20:757–769
Sánchez C, Zhu LL, Braña AF et al (2005) Combinatorial biosynthesis of antitumor indolocarbazole compounds. PANS 102:461–466
Nash TH (1996) Lichen biology. Cambridge: Cambridge University Press 1–7
Guschina IA, Dobson G, Harwood JL (2003) Lipid metabolism in cultured lichen photobionts with different phosphorus status. Phytochem 64:209–217
Hawksworth DL (1991) The fungal dimension of biodiversity: magnitude, significance, and conservation. Mycol Res 95:641–655
Hawksworth DL (2001) The magnitude of fungal diversity: the 1.5 million species estimate revisited. Mycol Res 105:1422–1432
DePriest PT (2004) Early molecular investigations of lichen-forming symbionts: 1986−2001. Annu Rev Microbiol 58:273–301
Nash TH (2008) Lichen biology, 2nd edn. Cambridge University Press, New York
Stocker-Wörgötter E (2008) Metabolic diversity of lichen forming ascomycetous fungi: culturing, polyketide and shikimate metabolite production, and PKS genes. Nat Prod Rep 25:188–200
Huneck S (1999) The significance of lichens and their metabolites. Naturwissenschaften 86:559–570
Bézivin C, Tomasi S, Lohézic-Le Dévéhat F, Boustie J (2003) Cytotoxic activity of some lichen extracts on murine and human cancer cell lines. Phytomed 10:499–503
Tomasz M (1995) Mitomycin C: small, fast and deadly (but very selective). Curr Biol 2:575–579
Lauterwein M, Oethinger M, Belsner K et al (1995) In vitro activities of the lichen secondary metabolites vulpinic acid, (+)-usnic acid, and (–)-usnic acid against aerobic and anaerobic microorganisms. Antimicrob Agents Chemother 39:2541–2543
Honda NK, Pavan FR, Coelho RG et al (2010) Antimycobacterial activity of lichen substances. Phytomedicine 17:328–332
Fazio AT, Adler MT, Bertoni MD et al (2007) Lichen secondary metabolites from the cultured lichen mycobionts of teloschistes chrysophthalmus and ramalina celastri and their antiviral activities. Z Naturforsch C 62:4360–4365
Neanati N, Hong HX, Mazumder A et al (1997) Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching. J Med Chem 40:942–952
Ren MR, Hur JS, Seo KI et al (2009) Anti-proliferative effects of Lethariella zahlbruckneri extracts in HT-29 human colon cancer cells. Food Chem T47:2157–2162
Mitrović T, Stamenković S, Marković S et al (2011) Antioxidant, antimicrobial and antiproliferative activities of five lichen species. Int J Mol Sci 12:5428–5448
Mitrović T, Stamenković S, S.tojičić D et al (2011) Lichen as source of versatile bioactive compounds. Biolog Nys-san 2:1−6
Zambare VP, Christopher LP (2012) Biopharmaceutical potential of lichens. Pharm Biol 50:778–798
Wei JC, Wang XY, Hou JL et al (1982) Lichenes officinales sinenses. Science Press, Beijing
Bastien JW (1983) Pharmacopoeia of the qollahuaya andeans. J Ethnopharmacol 8:97–111
Wang LS, Takao N, William LC et al (2001) Ethnic uses of lichens in Yunnan, China. Bryologist 104:345–349
Lokar LC, Poldini L (1998) Herbal remedise in the traditional medicine of the Venezia Giulia Region (north east Italy). J Ethnophar 22:231–178
Podterob AP (2008) Chemmical composition of lichen and their medical applications. Pharm Chem J 42:32–38
Vartia KO (1973) Antibiotics in lichens. In: Ahmadjian V, Hale ME (eds) The lichens. Academic Press, New York 547–569
Boustie J, Tomasi S, Grube M (2011) Bioactive lichen metabolites: alpine habitats as an untapped source. Phytochem Rev 10:287–307
Müller K (2001) Pharmaceutically relevant metabolites from lichens. Appl Microbiol Biotechnol 56:9–16
Triggiani1 D, Ceccarelli1 D, Loppi S et al (2009) Antiproliferative activity of lichen extracts on murine myeloma cells. Biologia 64:59−62
Bézinvin C, Tomasi S, Boustie J et al (2003) Cytotoxic activity of some lichen extracts on murine and human cancer cell lines. Phytomed 10:499–503
Perry NB, Benn MH, Tangney RS et al (1999) Antimicrobial, antiviral and cytotoxic activikty of New Zealand lichens. Lichenologi 31:627–636
Ranković BR, Kosanić MM, Stanjkvić TP (2011) Antioxidant, antimicrobial and anticancer activity of the lichens Cladonia furcata, Lecanora atra and Lecanora muralis. CAM 11:97–104
Kupchan M, Kopperman HL (1975) Usnic acid: tumor inhibitor isolated from lichens. Experientia 31:625
Bazin MA, Le Lamer AC, Delcros JG (2008) Synthesis and cytotoxic activities of usnic acid derivatives. Bioorg Med Chem 16:8737–8744
O’Neill MA, Mayer M, Appleyard VCL et al (2010) Does usnic acid affect microtubules in human cancer cells? Braz. J. Biol 70:659–664
Olafsdottir ES, Lngólfsdottir K (2001) Polysaccharides from lichens: structural characteristics and biological activity. Planta Med 67:199–208
Whistler RL, Bushway AA, Singh PP (1976) Noncytotoxic, antitumour polysaccharides. Adv Carbohydr Chem Biochem 32:235–275
Chihara G, Hamuro J, Maeda YY (1970) Fractionation and purification of the polysaccharides with marked antitumor activity, especially lentinan, from lentinus edodes (berk.) sing. (an edible mushroom). Cancer Res 30:2776–2781
Correche E, Carrasco M, Enriz D et al (2002) Cytotoxic screening activity of secondary lichen metabolites. Acta Farm Bonaerense 4:273–278
Russo A, Piovano M, Lombardo L (2006) Pannarin inhibits cell growth and induces cell death in human prostate carcinoma DU145 cells. Anti-canc D17:1163–1169
Ogmundsdottir HM, Zoega GM, Gissurarson SR (1998) Anti-proliferative effects of lichen-derived inhibitors of 5- lipoxygenase on malignant cell-lines and mitogenstimulated Lymphocytes. J Pharm Pharmacol 50:107–115
Haralsdottir S, Guolaugsdottir E, Ogmundsdóttir HM et al (2004) Anti-proliferative effects of lichen-derived lipoxygenase inhibitors on twelve human cancer cell lines of different tissue origin in vitro. Planta Med 70:1098–1110
Gissurarson SR, Sigurdsson SB, Ingólfsdóttir K et al (1997) Effect of lobaric acid on cysteinyl- leukotriene formation and contractile activity of guinea pig taenia coli. J Pharmacol Exp Ther 280:770–773
Millot M, Tomasi S, Boustie J et al (2009) Cytotoxic constituents of the lichen Diploicia canescens. J Nat Prod 72:2177–2180
Ernst-Russell MA, Elix JA, Nash IIITH et al (1999) Hybocarpone, a novel cytotoxicity naphthazarin derivative from mycobiont cultures of the lichen Lecanora hybocarpa. Tetrahedr L 40:6321–6324
Roullier C, Chollet-Krugler M, Boustie J et al (2010) A novel aryl-hydrazide from the marine lichen Lichina pygmaea: isolation, synthesis of derivatives and cytotoxicity assays. Bioorg Med 20:4582–4586
Liu YQ, Hu XY, Lou HX et al (2012) Rentigeric acid B exhibits antitumor activity through suppression of nuclear factor-kB signaling in Prostate cancer cells in vitro and in vivo. PLoS ONE 7:1–11
Acknowledgments
This work was financially supported by the Scientific Research Foundation for Ph.D, Southwest Forestry University and the Youth Innovation Promotion Association, Chinese Academy of Sciences
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Ren, M., Wei, X., Xu, F. (2014). Lichen: A Potential Anticancer Officinal Resource. In: Zhang, TC., Ouyang, P., Kaplan, S., Skarnes, B. (eds) Proceedings of the 2012 International Conference on Applied Biotechnology (ICAB 2012). Lecture Notes in Electrical Engineering, vol 250. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-37922-2_80
Download citation
DOI: https://doi.org/10.1007/978-3-642-37922-2_80
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-37921-5
Online ISBN: 978-3-642-37922-2
eBook Packages: EngineeringEngineering (R0)